Price T Rowe Associates Inc Turning Point Therapeutics, Inc. Transaction History

Price T Rowe Associates Inc

  • $869 Billion
  • Q3 2024

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$24.32 - $75.3 $73.2 Million - $227 Million
-3,008,738 Reduced 75.93%
953,914 $71.8 Million
Q1 2022

May 16, 2022
BUY
$24.73 - $51.25 $3.74 Million - $7.74 Million
151,084 Added 3.96%
3,962,652 $106 Million
Q4 2021

Feb 14, 2022
BUY
$35.48 - $67.33 $18.7 Million - $35.4 Million
525,687 Added 16.0%
3,811,568 $182 Million
Q3 2021

Nov 15, 2021
BUY
$61.0 - $81.99 $23.9 Million - $32.1 Million
391,786 Added 13.54%
3,285,881 $218 Million
Q2 2021

Aug 16, 2021
BUY
$62.93 - $90.59 $23.5 Million - $33.8 Million
373,052 Added 14.8%
2,894,095 $226 Million
Q1 2021

May 17, 2021
SELL
$88.19 - $140.01 $2.18 Million - $3.46 Million
-24,742 Reduced 0.97%
2,521,043 $238 Million
Q4 2020

Feb 16, 2021
BUY
$87.69 - $130.94 $223 Million - $333 Million
2,545,785 New
2,545,785 $310 Million

About Turning Point Therapeutics, Inc.

TPTX Quotes by TradingView
  • Ticker TPTX
  • Exchange NASDAQ
  • Shares Outstandng 50,074,300
More about TPTX
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email